Dr. Liu Jiayong
Tus kws kho mob tseem ceeb
Tam sim no nws yog tus lwm thawj coj ntawm Chav Haujlwm Pob Txha thiab Cov Nqaij Mos ntawm Tsev Kho Mob Cancer hauv Beijing. Nws kawm tiav ntawm Chav Haujlwm Tshuaj ntawm Peking University xyoo 2007 nrog rau daim ntawv kawm tiav qib siab hauv kev kho mob.
Kev Kho Mob Tshwj Xeeb
Tam sim no nws yog ib tug tswv cuab ntawm Pawg Sarcoma nqaij mos thiab Pawg melanoma ntawm Tuam Tshoj Tiv Thaiv Kab Mob Cancer. Nws tau cog lus rau kev kho mob sarcoma nqaij mos thiab kev phais mob melanoma. Daim ntawv thov ntawm 99Tcm-IT-Rituximab traced sentinel lymph node biopsy hauv daim tawv nqaij melanoma tau ua thawj zaug hauv Suav teb xyoo 2012.10. Xyoo 2010, nws tau qhia txog Phau Ntawv Qhia Kev Kho Mob ntawm NCCN Soft Tissue Sarcoma rau hauv Suav teb. Txij lub Kaum Hli 2008 txog Lub Kaum Ob Hlis 2012, nws yog ib tug kws tshawb fawb tuaj xyuas hauv National Cancer Institute of Japan. Nyob rau hauv xyoo tas los no, nws tau luam tawm ntau daim ntawv hais txog sarcoma nqaij mos thiab melanoma hauv cov ntawv xov xwm kho mob tseem ceeb.
Lub sijhawm tshaj tawm: Lub Peb Hlis-04-2023